Home > PJ (current issue) > News / News Centre | Search

PJ Online homeThe Pharmaceutical Journal
Vol 274 No 7342 p353
26 March 2005

This article
Reprint   Photocopy

  Acrobat Reader


News summary


No move to central medicines purchasing in Scotland

Current arrangements for purchasing medicines for the NHS are cost-effective and should be maintained, according to Scottish health minister Andy Kerr.

Answering a parliamentary question raised earlier this month about whether medicines should be purchased nationally for both primary care and hospital use, Mr Kerr said: “There are no current plans to do so. I believe that the current arrangements secure a cost-effective means of purchasing medicines for the NHS and that a combined system would sacrifice the advantages offered by the current separate arrangements.”

Mr Kerr continued: “Medicines dispensed by community pharmacists against NHS prescriptions are purchased and owned by the pharmacist. Once a medicine is dispensed, the pharmacist is reimbursed the cost of the item less a discount. The financial risk and the administrative costs are borne by the contractors and not the NHS.” Hospitals, he explained, use national and regional purchasing arrangements to take advantage of the collective purchasing power of NHS boards.

Scottish Pharmaceutical General Council chairman Frank Owens said: “In Scotland, at least, the minister’s statement should help remove anxieties over NHS purchasing policies and, more importantly, provide greater confidence for contractors as they prepare to deliver new pharmaceutical care services.”

Back to Top


©The Pharmaceutical Journal